IMUCEOM Pharmaceutical Holdings Inc.
Price Chart
Loading chart...
About EOM Pharmaceutical Holdings Inc. (IMUC)
EOM Pharmaceutical Holdings Inc. (IMUC) is a Biotechnology company headquartered in Montvale, NJ, United States whose shares trade over-the-counter on the Pink tier.
The Company is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Our development pipeline consists of multiple programs and clinical indications at various stages of development. Our portfolio currently consists of two product candidates: EOM613 and EOM147.
Products and services
The company is a clinical-stage biopharma company with a number of drug candidates in development for autoimmune, inflammatory, viral, and retinal diseases.
IMUC key facts
- Ticker symbol
- IMUC
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Montvale, NJ, United States
- Country of incorporation
- US
- Year of incorporation
- 1987
- Employees
- 4
- Estimated market cap
- $18.84M (as of Apr 10, 2025)
- Shares outstanding
- 126,502,860
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Unaudited
- Fiscal year end
- 12/31
- Latest filing
- Annual Report (Dec 31, 2024)
EOM Pharmaceutical Holdings Inc. leadership
- Irach B. Taraporewala, PhD. — CEO
- Eli Goldberger — COO
- Wayne I. Danson — CFO, Treasurer
- Dr. Shalom Hirschman — CMO
- Louis A. Brilleman, Esq. — Counsel
- William Gomes — Controller
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with I
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for EOM Pharmaceutical Holdings Inc. (IMUC) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...